TABLE 8.

Reported opioid medications in patients across all conditions following the cannabis‐based medicinal products (CBMP) treatment.

	Baseline	1 month	3 months	6 months	12 months	p‐Value	F‐value
Oils	140.16 ± 656.68	139.74 ± 656.74	133.90 ± 618.97	133.22 ± 619.08	133.47 ± 619.18	0.374	0.82
Dried flower	102.19 ± 436.83	102.23 ± 436.82	100.96 ± 437.09	96.22 ± 436.02	98.67 ± 435.57	0.316	1.07
Oils and dried flower	151.27 ± 607.30	150.90 ± 607.37	141.38 ± 599.67	139.51 ± 599.87	140.64 ± 600.96	0.223	1.51
Total	140.89 ± 616.60	140.53 ± 616.97	133.65 ± 594.06	132.07 ± 594.13	132.91 ± 594.61	0.039*	2.52

Note: Paired patient opioid usage in oral morphine equivalents was analyzed using repeated measures ANOVA. Opioid medications were reported as mean ± standard deviation.

^* p < 0.050;

^** p < 0.010;

^*** p < 0.001.